Healthcare entity

LivaNova

Company LIVN

market-trends is the sole category represented across all 1 tracked stories. Alkermes is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 20 original sources each against 4.7 for the same window.

Last mentioned: Feb 26, 2026

Entity pulse

Recent coverage · LivaNova

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about LivaNova

market-trends is the sole category represented across all 1 tracked stories. Alkermes is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 20 original sources each against 4.7 for the same window. The 7 average consequence score is above the beat benchmark of 5.6 in the same window. We currently track 1 Healthcare story that mention LivaNova, all published on February 26, 2026.

Stories tracked
1
Sources per story
20

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering LivaNova. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning LivaNova 1

Market Trends Positive

Health Tech Earnings: AI Integration and Orphan Drugs Drive Q4 Sector Growth

The Q4 2025 earnings cycle for healthcare and health IT firms reveals a sector-wide shift toward AI-driven diagnostics and high-margin orphan drug commercialization. While medical device firms face cyclical equipment sales challenges, specialized biotech and diagnostic players like Veracyte and Soleno are reporting record profitability and rapid market penetration.

20 sources

LivaNova is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.